CONTACT

+91 80 2808 2808

info@biocon.com

Press Releases 2022

Biocon / News – Posts / Press Releases / Press Releases 2022

University of Glasgow officially Opens Mazumdar Shaw Advance Research Centre

Thu, 09-Jun-2022
Posted by: BIOCON

Biocon Biologics and Viatris Launch Abevmy® (bBevacizumab), Their Third Oncology Biosimilar, in Canada

Thu, 19-May-2022
Posted by: BIOCON

Biocon Q4FY22 Revenue at Rs 2,476 Cr, Up 21%; Core EBITDA at Rs 815 Cr, Up 37% ; PBT(before Exceptional Items) at Rs 384 Cr, Up 9%

Thu, 28-Apr-2022
Posted by: BIOCON

Biocon Biologics’ Insugen® Awarded a Three-Year Contract by Ministry of Health, Malaysia

Tue, 26-Apr-2022
Posted by: BIOCON

Biocon Biologics’ Partner Receives Positive EU CHMP Opinion for Biosimilar Human Insulin for IV Infusion

Fri, 01-Apr-2022
Posted by: BIOCON

University of Glasgow Names their Flagship Research Centre After John Shaw and Kiran Mazumdar-Shaw

Tue, 29-Mar-2022
Posted by: BIOCON

Kiran Mazumdar-Shaw Elected as the Fellow of Royal Society of Edinburgh (RSE)

Kiran Mazumdar-Shaw Elected as the Fellow of Royal Society

Wed, 23-Mar-2022
Posted by: BIOCON

Biocon Biologics to Acquire Viatris’ Biosimilars Assets for up to USD 3.335 billion in Stock and Cash

Mon, 28-Feb-2022
Posted by: BIOCON

Biocon Q3FY22 Revenue at Rs 2,223 Cr, Up 18%; EBITDA at Rs 537 Cr, Up 25%; Biosimilars Up 28% at Rs 981 Cr; Research Services Up 10% at Rs 641 Cr; Generics Up 7% at Rs 607 Cr

Thu, 20-Jan-2022
Posted by: BIOCON